{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:37:10Z","timestamp":1786981030741,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10637-009-9316-7","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T22:47:13Z","timestamp":1252968433000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response"],"prefix":"10.1007","volume":"28","author":[{"given":"Brigette B.Y.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.Y.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fong","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C. Cesar","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Wai","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"key":"9316_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000312","volume":"9","author":"Q Tao","year":"2007","unstructured":"Tao Q, Chan AT (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9:1\u201324","journal-title":"Expert Rev Mol Med"},{"key":"9316_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hed.10307","volume":"25","author":"B Ma","year":"2003","unstructured":"Ma B, Poon T, To KF, Teo PML, Chan ML, Mo KF, Ma B, Lai MP, Ho S, Chan ATC (2003) Expression and prognostic significance of epidermal growth factor receptor and HER2 protein in nasopharyngeal carcinoma. Head Neck 25:864\u2013872","journal-title":"Head Neck"},{"key":"9316_CR3","first-page":"237","volume":"19","author":"FL Sung","year":"2005","unstructured":"Sung FL, Poon TC, Hui EP, Ma BB, Liong E, To KF, Huang DP, Chan AT (2005) Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo 19:237\u2013245","journal-title":"In Vivo"},{"key":"9316_CR4","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","volume":"23","author":"AT Chan","year":"2005","unstructured":"Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, Mueser M, Amellal N, Lin X, Chang AY (2005) Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 23:3568\u20133576","journal-title":"J Clin Oncol"},{"key":"9316_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00280-007-0575-8","volume":"62","author":"B Ma","year":"2008","unstructured":"Ma B, Hui EP, King A, To KF, Mo F, Leung SF, Kam M, Lo YM, Zee B, Mok T, Ahuja A, Chan AT (2008) A phase II study of gefitinib patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy. Cancer Chemother Pharmacol 62:59\u201364","journal-title":"Cancer Chemother Pharmacol"},{"key":"9316_CR6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1124\/mol.106.032284","volume":"71","author":"VW Lui","year":"2007","unstructured":"Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M, Grandis JR (2007) Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1. Mol Pharmacol 71:1435\u20131443","journal-title":"Mol Pharmacol"},{"key":"9316_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.onc.1209839","volume":"26","author":"TJ Seng","year":"2007","unstructured":"Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q (2007) The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26:934\u2013944","journal-title":"Oncogene"},{"key":"9316_CR8","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1158\/0008-5472.CAN-07-2536","volume":"67","author":"J Adelaide","year":"2007","unstructured":"Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, Charafe-Jauffret E, Cervera N, Desplans J, Parzy D, Schoenmakers E, Viens P, Jacquemier J, Birnbaum D, Bertucci F, Chaffanet M (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67:11565\u201311575","journal-title":"Cancer Res"},{"key":"9316_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jhep.2004.08.024","volume":"41","author":"M Hopfner","year":"2004","unstructured":"Hopfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherubl H (2004) Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J Hepatol 41:1008\u20131016","journal-title":"J Hepatol"},{"key":"9316_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ijc.20362","volume":"112","author":"L Bonaccorsi","year":"2004","unstructured":"Bonaccorsi L, Carloni V, Muratori M, Formigli L, Zecchi S, Forti G, Baldi E (2004) EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). Int J Cancer 112:78\u201386","journal-title":"Int J Cancer"},{"key":"9316_CR11","first-page":"503","volume":"18","author":"C Festuccia","year":"2007","unstructured":"Festuccia C, Gravina GL, Millimaggi D, Muzi P, Speca S, Ricevuto E, Vicentini C, Bologna M (2007) Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells. Oncol Rep 18:503\u2013511","journal-title":"Oncol Rep"},{"key":"9316_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ijc.20550","volume":"113","author":"SW Han","year":"2005","unstructured":"Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK (2005) Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer. Int J Cancer 113:109\u2013115","journal-title":"Int J Cancer"},{"key":"9316_CR13","first-page":"7443","volume":"63","author":"B Li","year":"2003","unstructured":"Li B, Chang CM, Yuan M, McKenna WG, Shu HK (2003) Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Cancer Res 63:7443\u20137450","journal-title":"Cancer Res"},{"key":"9316_CR14","first-page":"467","volume":"20","author":"AB Hui","year":"2002","unstructured":"Hui AB, Lo KW, Teo PM, To KF, Huang DP (2002) Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 20:467\u2013473","journal-title":"Int J Oncol"},{"key":"9316_CR15","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1200\/JCO.2005.01.0793","volume":"23","author":"T Takano","year":"2005","unstructured":"Takano T, Ohe Y, Sakamoto H, Tsuta K, Matsuno Y, Tateishi U, Yamamoto S, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Shibata T, Sakiyama T, Yoshida T, Tamura T (2005) Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 23:6829\u20136837","journal-title":"J Clin Oncol"},{"key":"9316_CR16","first-page":"3","volume":"20","author":"L Ferrer-Soler","year":"2007","unstructured":"Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R (2007) An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). Int J Mol Med 20:3\u201310","journal-title":"Int J Mol Med"},{"key":"9316_CR17","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-05-3753","volume":"66","author":"MS Pino","year":"2006","unstructured":"Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, McConkey DJ (2006) Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Cancer Res 66:3802\u20133812","journal-title":"Cancer Res"},{"key":"9316_CR18","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1093\/hmg\/ddh331","volume":"13","author":"S Kakiuchi","year":"2004","unstructured":"Kakiuchi S, Daigo Y, Ishikawa N, Furukawa C, Tsunoda T, Yano S, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M, Sone S, Nakamura Y (2004) Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet 13:3029\u20133043","journal-title":"Hum Mol Genet"},{"key":"9316_CR19","first-page":"319","volume":"19","author":"WK Yip","year":"2008","unstructured":"Yip WK, Leong VC, Abdullah MA, Yusoff S, Seow HF (2008) Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol Rep 19:319\u2013328","journal-title":"Oncol Rep"},{"key":"9316_CR20","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1158\/0008-5472.CAN-04-0538","volume":"64","author":"MJA GM","year":"2004","unstructured":"GM MJA, Pathmanathan R, Raab-Traub N (2004) Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64:5251\u20135260","journal-title":"Cancer Res"},{"key":"9316_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ncb0901-802","volume":"3","author":"LSY MK","year":"2001","unstructured":"MK LSY, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3:802\u2013808","journal-title":"Nat Cell Biol"},{"key":"9316_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jnci\/djh217","volume":"96","author":"F Cappuzzo","year":"2004","unstructured":"Cappuzzo F, Magrini E, Ceresoli GL, Bartolini S, Rossi E, Ludovini V, Gregorc V, Ligorio C, Cancellieri A, Damiani S, Spreafico A, Paties CT, Lombardo L, Calandri C, Bellezza G, Tonato M, Crino L (2004) Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 96:1133\u20131141","journal-title":"J Natl Cancer Inst"}],"updated-by":[{"DOI":"10.1007\/s10637-010-9397-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T00:00:00Z","timestamp":1266192000000}}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-009-9316-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9316-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T23:36:56Z","timestamp":1678491416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-009-9316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1007\/s10637-009-9316-7","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]},"assertion":[{"value":"10 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}